XOMA Royalty (XOMA) FCF Margin Growth (3y) (2014 - 2026)
XOMA Royalty (XOMA) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
117,646.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
117,646.00 |
| Dec 31, 2025 |
24,895.00 |
| Sep 30, 2025 |
68,064.00 |
| Jun 30, 2025 |
56,792.00 |
| Mar 31, 2025 |
8,743.00 |
| Dec 31, 2024 |
-1.59 Mn |
| Sep 30, 2024 |
-3.42 Mn |
| Jun 30, 2024 |
49,545.00 |
| Mar 31, 2024 |
-8,942.00 |
| Dec 31, 2023 |
-27,834.00 |
| Sep 30, 2023 |
18,445.00 |
| Jun 30, 2023 |
-40,128.00 |
| Mar 31, 2023 |
-67,077.00 |
| Dec 31, 2022 |
72,116.00 |
| Sep 30, 2022 |
-85,510.00 |
| Jun 30, 2022 |
-11,765.00 |
| Mar 31, 2022 |
-15,876.00 |
| Dec 31, 2021 |
1.55 Mn |
| Sep 30, 2021 |
-2,088.00 |
| Jun 30, 2021 |
-29,266.00 |
